Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Weak cold and flu season hits sales at Reckitt Benckiser
(Sharecast News) - Shares in Reckitt Benckiser Group fell on Wednesday, after a weak cold and flu season weighed on first-quarter trading. The owner of Durex, Dettol, Vanish, Nurofen and Strepsils, among many others, posted a 1.3% rise in core like-for-like sales in the first three months of the year. Within that, revenues in Europe fell 4.2% and by 0.9% in North America. But emerging markets fared better, with a 7.6% spike in sales.
Group sales - which include the Mead Johnson baby formula business, which is slated for disposal - were up 0.6%.
Kris Licht, chief executive, said trading had been affected by "very low seasonal incidence, weak categories in Europe and geopolitical disruption". Once seasonal over the counter drugs were stripped out, sales rose 3.1%, he noted.
As at 0900 BST, the blue chip was down 5% at 4,670p.
However, looking forward and the blue chip maintained full-year guidance for like-for-like core sales growth of between 4% and 5%.
"While acknowledging the current uncertainty arising from the war in the Middle East," Reckitt said, "through 2026 we expect to benefit from the rest of the cold and flu season as well as the launch of superior innovations across our categories.
"We are driving continued momentum across our North American non-seasonal portfolio and are taking actions to improve our execution in Europe."
However, it also flagged that should oil prices remain elevated, costs would rise, though they would largely be offset by flexibility in the supply chain, its hedging strategy and pricing.
The planned disposal of Mead Johnson Reckitt is part of wider plans by Reckitt to refocus on its core brands. It sold a majority stake in its Essential Home business in December to private equity firm Advent International for $4.8bn.
Richard Hunter, head of markets at Interactive Investor, said: "The sale of Mead Johnson remains high on the to-do list, but with the Essential Homes disposal complete, core Reckitt is edging towards its strategic objective of concentrating on its most established and highest margin power brands.
"Growth remains on track, despite some headwinds.
"While stocks such as Reckitt will never be seen as racy or high fashion, they are nonetheless rather more solid and dependable. These defensive characteristics can come into their own in market environments such as these."
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.